| 000 | 01676 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513145613.0 | ||
| 264 | 0 | _c19980804 | |
| 008 | 199808s 0 0 eng d | ||
| 022 | _a0077-8923 | ||
| 024 | 7 |
_a10.1111/j.1749-6632.1998.tb11024.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTim, R W | |
| 245 | 0 | 0 |
_aLambert-Eaton myasthenic syndrome (LEMS). Clinical and electrodiagnostic features and response to therapy in 59 patients. _h[electronic resource] |
| 260 |
_bAnnals of the New York Academy of Sciences _cMay 1998 |
||
| 300 |
_a823-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a4-Aminopyridine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAmifampridine |
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 |
_aCarcinoma, Small Cell _xcomplications |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aElectrodiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aLambert-Eaton Myasthenic Syndrome _xdiagnosis |
| 650 | 0 | 4 |
_aLung Neoplasms _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPlasmapheresis |
| 650 | 0 | 4 |
_aPyridostigmine Bromide _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptors, Cholinergic _ximmunology |
| 700 | 1 | _aMassey, J M | |
| 700 | 1 | _aSanders, D B | |
| 773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 841 _gp. 823-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1749-6632.1998.tb11024.x _zAvailable from publisher's website |
| 999 |
_c9634306 _d9634306 |
||